DexCom, Inc. USDC – Southern District of New York october 1, 2024 CLASS PERIOD: february 15, 2024 – july 24, 2024LEAD PLAINTIFF DEADLINE:october 15, 2024 Join Investigation Principle Contacts Pamela MayerPMayer@kaplanfox.comLaurence D. KingLKing@kaplanfox.com Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Stellantis N.V. (STLA) – Deadline is October 15, 2024 Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Stellantis N.V. (“Stellantis” or the “Company”) (NYSE: STLA) securities between February 15, 2024 and July 24, 2024 (the “Class Period”). CLICK HERE TO JOIN THE CASE If you are an investor in Stellantis and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing pmayer@kaplanfox.com or by calling (646) 315-9003. DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than October 15, 2024 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. On July 25, 2024, Stellantis disclosed in a semi-annual financial report for the first six months of 2024, that the Company had missed consensus estimates and were expecting a disappointing “near-term outlook.” On this news, the price of Stellantis fell $1.94 per share, nearly 10% over the next two trading days to close at $17.66 on July 26, 2023. WHY CONTACT KAPLAN FOX Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. If you have any questions about this Notice, your rights, or your interests, please contact: CONTACT:Pamela A. MayerKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(646) 315-9003pmayer@kaplanfox.com Laurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1560Oakland, California 94612(415) 772-4704lking@kaplanfox.com Connect with Kaplan Fox. Receive a complimentary case review now. Contact Us Quanterix Corp See the Case MediaAlpha, Inc. See the Case PACS Group, Inc. See the Case WM Technology See the Case Humacyte, Inc. See the Case Acadia Healthcare Company, Inc. See the Case Edwards Lifesciences Corporation See the Case United Parcel Service, Inc. See the Case Elanco Animal Health Incorporated See the Case Iris Energy Ltd See the Case Toronto-Dominion Bank See the Case Fluence Energy, Inc. See the Case
